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L-3,4-Dih ydroxy phenyl alanine (L-dopa) and its structura l 
analogs are known to be po tentl y cy totoxic to melan o m a 
cell s. We examined the effects of cys tein ylcatecho ls and 
related co mpo unds, w hi ch were newly synth es ized as cys-
teiny l derivat ives o f L-dopa, o n the g rowth o f hum an mel-
ano m a cell s in vitro, and th eir ac tio ns we re co mpared w ith 
those of L-dopa. 4-S- and 3-S-Cystein y lcatechols showed 
sig nifi ca ntl y m o re po tent cy to tox icity to melano m a cell s 
than did L-dopa , and 2- S-cyste in ylh yd roquin o ne was nex t 
P o lyphcnoli c in term cdiates in the fo rm at io n of melanin from tyrosine arc known to be po tenti all y cyto tox ic agents /1 -3 /. Wi ck et al showed that L-3,4-dih yd rox-yp henylalanin e (L-do pa) is select ivel y tox ic to mel a-no m a ce lls in vitro f4 / and that its chemi cal ana logs also 
ex hibit antitum o r act ivit y in experimental tum o r syste m s /5-91. 
Recentl y . Ito . et al fl O/ fo un d that 5-S-cyste in y l-3,4-di -
hyd roxyphenylalanine (5- S-cystein y ldo pa), an interm ed iate in thc 
m etabo li c pathway fro l11 L-dopa to pheo m clanin , is mu ch m o re 
cy totox ic than L- dopa itself and suggested that the catecho ls w ith 
the cys te in yl g ro up show a potent antitum o r activity . In an at-
tempt to obta in m ore e ffcctive agents, we have new ly sy nthes ized 
var ious cysteinyl derivatives as st ru ctural ana logues of L-do pa and 
studied the effects of these dru gs o n the g rowth of cu ltured hUl11 an 
m ali g nan t melano m a ce lls. 
MAT ER IALS AND M ET H ODS 
Chemicals T he 7 new dru gs were sy nthes ized by o ne of the 
au tho rs (S. I. ); the deta il s o f the che mi ca l sy nth es is h;lVc bem 
reported elscw he re /11/ . T he dru gs co uld be class ified in to 2 
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Abbreviat ions: 
I.-dopa: L-3.4-d ih ydroxy phenylabnilll' 
IC,,,: SO'y-, growth inhibition concelltration 
2-S-C H: 2-S-cys teinylh ydroquinone 
2-S-C I<: 2-S-cysteinylreso rcin ol 
3-S-CC: 3-S-cystcin yJcatechol 
3-S-C-S-M C: 3-S-cys tein yl-5- lll eth ylGltechul 
4-S-CA 1': 4-S-cystca lllill ylphcll ol 
4-S-C P: 4-S-cysteiny lphcnol 
4-S-CC: 4-S-cys tein ylca techol 
to the ca techo ls in po ten cy. The mechani sm of act ion m ay 
invo lve interac tio n w ith the m elan ocy te-specifi c enzym.e, 
tyros in ase, fo r wh ich th e cys tein ylcatecho ls could beco m e 
a better substrate than L-dopa itself. 4-S-Cysteaminyl-
phen ol was alm ost co mparable to L- dopa in cy totox icity, 
suggesting that thi s phenol mig ht be oxidized to the cor-
respondin g ca techol by tyrosinase within the m elanoma 
cell s. J Invest Derrnafo/ 88:538-540, J 987 
g roups o n the basis of che mi ca l stru ctures; o ne was the dipheno l 
group , w hi ch contained 2 hydroxyl g roups as side chains . Th.is 
g roup included 4-S-cystei ny lcatechol (4-S-CC) , 3-S-cys tein y l-
catecho l. H C I. H 20 (3-S-CC), 3-S-cyste in y l-5-methylcatecho l (3-
S- C -5-M C), 2- S- cystein ylh ydroguin o ne (2-S-CH), and 2-S- cys-
tei ny lreso rcin o l (2-S-C R) . 4-S-Cystein ylca techo l had the chem-
ica l st ru cture in w hi ch o nl y a sulfur ato m was introdu ced into a 
m o lecule of L-dopa . T he o the r g ro up was ph eno l, and it included 
4-S-cyste:1minylpheno l (4-S-CAP) and 4-S-cystein y lph enol (4-S-
C Pl. L-Dopa was purchased fro m Sig m a C he mica l Co. (St. Lo uis, 
Mi sso uri) . All the dru g so lu t io ns were fres hl y prepared in Ham 's 
F-l0 m cdium (G ibco Labo rato ries, G rand Island, N ew York) just 
bcfo rc usc at the beg innin g o f each ex perim ent. 
Cells T he human malig nant m elano m a cell lin e (HMV-I) used 
in this study was estab li shed from a black-brown mali gnant m el-
ano ma in the vagina l wa ll of a 65-yea r-old wo m an [1 2]. The 
HMV-I ce ll s were m aintain cd in I-la m 's F-l0 m edium supple-
m cnted with 10°;(, calf scrum (Flow Labo rato ries In c., Rockv ille, 
Mary land), penicillin (100 U / ml) , and streptom ycin (100 J.Lg/ml ), 
and in cubated in a humidifi ed atm ospherc of 95% air and 5% 
CO2 at 3rc. 
Effects of the Drugs 011 Cell Growth Cell s ( I X 105) were 
plated in 35-mm plasti c dishes (tissue culture Petri di sh ; Falco n). 
After 4H h of in cubati o n , the m edium was repla ced w ith fresh 
culture m ed ium containin g th e desired concentratio ns o f each 
dru g. T he range o f dru g concentrations was from 2 J.Lg/ml to 2 .2 
mg/ llll , although it va ri ed dependin g o n e ffects o f the drugs. 
Dup li cate cultures we re set up at each o f the concen trat io ns. For 
each drug, assays we re perfo rm ed at lea st 3 tim es. After 48 h of 
dru g ex pos ure at 37°C, th e m edium was rem oved and the cells 
were trypsi ni zed. The III 1111 bel' of ce ll s per d ish , assessed by trypan 
blue cx clusio n , was determin cd mi crosco pi call y with a hemo-
cyto m eter. Und er th e ex perimental conditi o ns prov ided , th e av-
e rage do ublin g tim c of contro l ce ll s was 21.0 h. 
T he avera gc numbe r of ce ll s in each t reated culture was ex-
pressed as a percen ta ge o f the average num ber of cells in the 
co ntro l cul tures w ith o ut dru gs . The IC su value was defi ned as the 
0022-202X/S7/S03.50 Co pyright © 1'.J87 by T he Society for In vest iga tive Dermatology. Inc. 
538 
VOL. 88. NO. 5 MAY 1987 
dosc effective in inhibiting 50% of the cell population growth 
after 48 h of exposure to the drug. T he ICs" va lue was determined 
from a linear reg ress ion w ith the aid of a computer. T he sign if-
icance of d iffe rence of response to different dru gs was based on 
Stu dcnt 's (-test . 
RESULTS 
Figure 1 shows the dose-response curve of eKh drug to HMV-
I hu rn an Ill elano ma ce lls after 48 h of drug ex pos ure, and the ICs" 
valu e of each d ru g was summari zed in Table I. 
T h e IC so value of3-S-CC was 12.6 p,g/ ml and that of 4- S-CC, 
15.7 p,g/ml ; the 2 cystein ylcatecho ls showed the most potent 
grovvth-inhibitory effect of the dru gs exa mined in this stud y. T he 
leso va lue of I.-dopa exa mined fo r the purpose of co mparison 
was 22.5 p,g/ml , and 3-S- CC and 4- S-CC had a significantl y 
potent effect on HMV-I cell s compared with L-dopa (p < 0.05 
for each drug). 
2-S-Cystein y lhydroq uin one had an IC so value of 25.4 p,g/ml. 
T his was next to the 2 cysteinylcatechols in potency and was 
com.parable to I.-dopa 0) > 0.(5). However, the IC so va lue of 3-
S-C-5-MC was 29.4 p,g/m l , about 2 times larger than that o f 3-
S-CC 0J < 0.05), and this in dicated that the introduction of a 
meth yl group in the C-5 position ofJ-S- C resulted in a decrease 
of tbe effectiveness. 2-S-Cystein ylresorcino l had an IC so value of 
244 .3 p,g/m l and was the least effective of the diphenols. 
With respect to the pheno ls, the IC so va lue of 4-S-CAP was 
24.1 p,g/m l, and this phenol showed a g rowth-inhibi to ry effect 
cOlJlpara ble to L-dopa, a ca techoli c compo und 0) > 0.05) . H ow-
ever, 4-S-CP had an IC so value of952.2 p,g/ ml and was the least 
effective. 
D ISCUSSION 
3-S-Cystein ylcatechol and 4-S-CC showed the most potent growth-
inhibitory effect of the drugs exa mined in thi s stud y and we re 
significa ntly mo re effective than L-dopa, another ca techol. In gen-
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Table I. Fifty Percent G rowth Inhi biti on Concentration 
(IC su) of the Drugs to HMV-I Human Melanoma Cells 
ICsu ICs" Ratio Significance 
Drug (J.1g/ ml)·' (I.-dopa/drug) (p va lue)I' 
3-S-CC 12.6 1.79 < 0.05 
4-S-CC \5.7 1. 43 < 0.05 
L-Dopa 22.5 1.00 
4-S-CAP 24. 1 0.93 > 0.05 
2-S- H 25.4 0.89 > 0.05 
3-S-C-S-MC 29.4 0.77 < 0.05 
2-S-CH 244.3 0.09 < 0.0 1 
4-5- P 952.2 0.02 < 0.01 
"Each ICslI va llie is an average of values fro m 3-5 scp:t r:ltc experi ment s. 
I'T he signi fi cance vns c:llcubtcd between L-dopa ;l1ld o ther dru gs as described in 
}\ifafl'rifl/s ami JVlcr/wds . 
era l, 2 mechanisms have been postulated concerning the cy to-
toxicity of catechols [6,7, 13]; one is that catechols are converted 
to the correspo nding benzoq uinones, and the quinones produce 
dama ge to th e cell s through inactivation of sulfhydryl enzy mes, 
such as D NA po lymerase cr, which playa centra l role in the cell 
growth. T he other mechanism is that the catechols are auto-
oxid ized to produce cytotoxic hydrogen peroxide, superox.ide, 
and hydroxy l radicals. It is well known that , in melanoma cells, 
the conversio n of L-dopa and its analogs to quinones can be me-
diated by the specifi c enzy me tyrosinase [14], and the quinones 
have been demonstrated to have a marked affi ni ty for th e sulfhy-
dry l enzy mes [2] and form cova lent binding w ith th e sulfh yd ryl 
gro ups 11 5]. 
T he reason w hy the cysteillylcatecho ls are more cytotoxic to 
melanoma cells than L-dopa is yet to be studied . However, it 
could be ascribed to the presence of a sulfur ato m in their m ol-
ecule. The sul fur atom call in crease lipophi lic properties and pro-
0.1 1 
CONCENTRA TION (mg/ml) 
Figure 1. Effects of the drugs on the growth of I-I M V -I human Illclanoma cell s. Thc cells were exposcd to the different drug conccntrations in the 
conditions described in Mr/l cri(/Is (/wl Metliods. The res ul ts were expressed as the perccntage of control cell growth aftcr 48 h of drug exposure. Va lues 
represent mean ± 5E of 3-5 determinations. Opell tri(/ligles, 3-5- C; closed circles, 4-5-CC; OpCII circles, L-dopa; closed Sq"afCS, 4-5-CAP; opell sqrwrcs, 
2-S-CH ; closed (rial/s ics, 3-5-C-5-MC; six-sided stnrs, 2-S-CR; jille-sidcd S((/rS, 4-5- P. 
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mote effi cicnt uptake into th e cells [11]. In addition . our ongoing 
stud y indica tcd th at the cysteinylcatccho ls could beco me a better 
substratc fo r tyrosinase prepared from mushroom and mam-
malian mela noma cells than L-dopa. This may bc due to the 
elcctron-donatin g rcsonance effcct o f the sulfur atom. which can 
incrcasc thc affinit y fo r tyrosinasc [1 6]. 
2-S-Cystcin ylh ydroquinonc w as sccond to the catcchols in cy-
to toxicity. H ydroquinone itself has becn known to have selectivc 
toxicity against mclanocytes in vivo and is used clinically as a 
depigmcnting agcnt [17. 18]. C havin ct al [1 9] showcd that hy-
droquinonc signifi cantly prolongs thc survival o f melanoma-bearing 
micc. Rcccntl y. Pcnney et al [201 sugges ted th at the cytotoxicity 
of hydroquinonc to melano ma cell s may be via its oxidation by 
ty rosinasc . T hereforc. it is possible th at the cy to toxicity of 2-S-
C H to melanoma cells. comparable to L-dopa in po tcncy. is also 
duc to its tyrosinasc-mcdiated oxidation. 2-S-Cystcinylresorcinol 
was thc Icast effccti vc among the diphenols. and thi s may be duc 
to thc fac t that rcsorcinol is chemica lly unablc to undcrgo oxi-
dation to a quinonc [21]. 
O ur rcsults dcm onstrate that 4-S-C AP. a phcnol . is much more 
cyto toxic to melanoma cells than is 4-S-CP . ano th er phenol . and 
4-S-C AP is almost comparable to L-dopa. a catecho l. in potency. 
The rcason for this is no t c1car at present. How evcr. removal o f 
the ca rboxyl group from 4-S-C P can incrcase the lipophilic prop-
erties. and thcre may be effi cient uptakc into th e cells [11]. It is 
possible that 4-S-C AP incorpo ratcd into melanoma cells is oxi-
dizcd by tyrosinase to produ ce the corresponding catecho l. which 
in turn cxcrts a po tcnt cytotoxic effcct comparable to L-dopa. 
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